Insulin Management for Steroid‑Induced Hyperglycemia

Choice of Basal Insulin

• The American Diabetes Association (2025) recommends using NPH insulin administered in the morning rather than a long‑acting basal analog (e.g., Lantus) for steroid‑induced hyperglycemia, because the intermediate‑acting profile (peak 4–8 h) aligns with the typical afternoon glucose surge caused by morning dexamethasone. 1

Initial Basal Dose

• Start NPH at 0.2 units /kg / day given once in the morning for patients with steroid‑induced hyperglycemia; this dose is supported by multiple ADA‑endorsed sources. [2][1]3
• For a patient weighing ≈109 kg, the calculated starting dose is 22 units of NPH in the morning (0.2 × 109 ≈ 22). 2
• An A1c of ~8 % (moderate hyperglycemia) justifies this conservative basal starting dose, as it reflects intermediate glycemic control. 4
• Beginning with the low‑dose regimen reduces the risk of hypoglycemia while permitting safe upward titration as steroid exposure continues. [2][1]

Prandial Insulin Initiation

• Use a carbohydrate‑to‑insulin ratio of 1 unit per 10 g of carbohydrate as the initial prandial dosing rule for insulin‑naïve patients with moderate control. 5
• Add 4 units of rapid‑acting insulin before the meal that shows the greatest post‑prandial glucose rise (typically lunch or dinner when dexamethasone peaks). [6][7]2
• If a more cautious approach is preferred, administer approximately 10 % of the basal dose (2–3 units) as prandial insulin. [6][7]
• The ADA (2025) advises starting prandial insulin with the meal that exhibits the largest post‑prandial glucose excursion. [1][3]

Correction and Titration Strategies

• Target fasting plasma glucose 90–150 mg/dL; this range guides basal dose adjustments. [2][1]
• For pre‑meal glucose >250 mg/dL, give an additional 2 units of rapid‑acting insulin; for >350 mg/dL, give 4 units. 8
• Increase the morning NPH dose by 2 units every 3 days if ≥50 % of fasting readings exceed the target, providing a structured titration algorithm. [2][1]3

Monitoring and Ongoing Dose Adjustment

• Check fasting glucose daily to evaluate the adequacy of the morning NPH dose and to inform titration. [2][1]
• Measure pre‑lunch and pre‑dinner glucose to verify that NPH coverage matches the afternoon steroid‑induced glucose peak. 8
• Watch for an elevated bedtime‑to‑morning glucose differential or a large post‑prandial‑to‑pre‑prandial gap, which signal insufficient basal or prandial insulin and prompt dose modification. [6][2]1

Transition and Hypoglycemia Prevention

• If recurrent hypoglycemia occurs with NPH, consider switching to a morning‑dosed basal analog (e.g., Lantus) as a second‑line option. 1
• Reduce the total insulin dose by 10–20 % when unexplained hypoglycemia appears, to mitigate further low glucose events. [6][7][2][1]3
• When dexamethasone is discontinued, lower the overall insulin dose by 35–50 % to avoid rebound hypoglycemia. [6][7]

All recommendations are derived from American Diabetes Association guidelines (2025) and supporting Diabetes Care publications, reflecting strong guideline‑level evidence.